Jinhui Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony K C Chan, Li Han, Christopher D Delaney, Xueer Wang, Elizaveta Mukhaleva, Mingli Li, Lu Yang, Sheela Pangeni Pokharel, Nicole M Mattson, Michelle Garcia, Bintao Wang, Xiaobao Xu, Leisi Zhang, Priyanka Singh, Zeinab Elsayed, Renee Chen, Benjamin Z Kuang, Jinhui Wang, Yate-Ching Yuan, Bryan Chen, Lai N Chan, Steven T Rosen, David A Horne, Markus Müschen, Jianjun Chen, Nagarajan Vaidehi, Scott A Armstrong, Rui Su, Chun-Wei David Chen
Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery. Science advances 10 (8) (2024)
Anthony K C Chan, Li Han, Christopher D Delaney, Xueer Wang, Elizaveta Mukhaleva, Mingli Li, Lu Yang, Sheela Pangeni Pokharel, Nicole M Mattson, Michelle Garcia, Bintao Wang, Xiaobao Xu, Leisi Zhang, Priyanka Singh, Zeinab Elsayed, Renee Chen, Benjamin Z Kuang, Jinhui Wang, Yate-Ching Yuan, Bryan Chen, Lai N Chan, Steven T Rosen, David A Horne, Markus Müschen, Jianjun Chen, Nagarajan Vaidehi, Scott A Armstrong, Rui Su, Chun-Wei David Chen
Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery. Science advances 10 (8) (2024)
Anthony K C Chan, Li Han, Christopher D Delaney, Xueer Wang, Elizaveta Mukhaleva, Mingli Li, Lu Yang, Sheela Pangeni Pokharel, Nicole M Mattson, Michelle Garcia, Bintao Wang, Xiaobao Xu, Leisi Zhang, Priyanka Singh, Zeinab Elsayed, Renee Chen, Benjamin Z Kuang, Jinhui Wang, Yate-Ching Yuan, Bryan Chen, Lai N Chan, Steven T Rosen, David A Horne, Markus Müschen, Jianjun Chen, Nagarajan Vaidehi, Scott A Armstrong, Rui Su, Chun-Wei David Chen
Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery. Science advances 10 (8) (2024)
Xiaobao Xu, Anthony K C Chan, Mingli Li, Qiao Liu, Nicole Mattson, Sheela Pangeni Pokharel, Wen-Han Chang, Yate-Ching Yuan, Jinhui Wang, Roger E Moore, Patrick Pirrotte, Jun Wu, Rui Su, Markus Müschen, Steven T Rosen, Jianjun Chen, Lu Yang, Chun-Wei David Chen
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Science advances 8 (51) (2022)
Xiaobao Xu, Anthony K C Chan, Mingli Li, Qiao Liu, Nicole Mattson, Sheela Pangeni Pokharel, Wen-Han Chang, Yate-Ching Yuan, Jinhui Wang, Roger E Moore, Patrick Pirrotte, Jun Wu, Rui Su, Markus Müschen, Steven T Rosen, Jianjun Chen, Lu Yang, Chun-Wei David Chen
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Science advances 8 (51) (2022)
Xiaobao Xu, Anthony K C Chan, Mingli Li, Qiao Liu, Nicole Mattson, Sheela Pangeni Pokharel, Wen-Han Chang, Yate-Ching Yuan, Jinhui Wang, Roger E Moore, Patrick Pirrotte, Jun Wu, Rui Su, Markus Müschen, Steven T Rosen, Jianjun Chen, Lu Yang, Chun-Wei David Chen
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Science advances 8 (51) (2022)
Xiaobao Xu, Anthony K C Chan, Mingli Li, Qiao Liu, Nicole Mattson, Sheela Pangeni Pokharel, Wen-Han Chang, Yate-Ching Yuan, Jinhui Wang, Roger E Moore, Patrick Pirrotte, Jun Wu, Rui Su, Markus Müschen, Steven T Rosen, Jianjun Chen, Lu Yang, Chun-Wei David Chen
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Science advances 8 (51) (2022)